Alzheimer's - ADDF/AFTD Frontotemporal Dementia Drug Discovery Programme 2013 ($ 150,000)

The Alzheimer's Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) invite applications for the Frontotemporal Dementia Drug Discovery Programme. Deadline for submission of a full proposal is September 5, 2013. The Letter of Intent is due two weeks before the proposal deadline. Research investigating the pathologic mechanisms of neurodegeneration in frontotemporal dementia (FTD) and related disorders is advancing, creating new potential targets for drug discovery. The ADDF and AFTD seek to accelerate and support drug discovery for FTD and related dementias through this Request for Proposals. Grants are provided for one-year duration (up to $ 150,000 each) with the possibility of follow-on funding. This funding does not support basic research.

ADDF funds drug discovery research programmes from investigators in academia and biotechnology companies. In addition, ADDF initiates, sponsors, and co-sponsors conferences to stimulate new ideas and approaches in areas of interest to the Foundation, bringing together physicians, scientists, and policy makers worldwide.